Approval · Notice of Compliance 21198 · 2018
CYSVIEW: Notice of Compliance 21198
Issued August 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21198
- Date
- August 10, 2018
- Company
- BioSyent Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the carton labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSVIEW | Not yet assigned | — |
Medicinal ingredients
- HEXAMINOLEVULINATE HYDROCHLORIDE 100 MG per VIAL